A father was crying over the death of his daughter. She was only twenty-one years old when she found out that she had a unique illness called squamos cell carcinoma. The father and daughter sought for every type of medication, but none of those available at hospital could heal her deadly illness. Her last resort was using experimental medical treatment, cetuximab and gefitinib to name a few. However, unfortunately, these medicines were undergoing clinical trials at the moment and she didn’t meet the inclusion criteria to take part in the trial. A few months later, the daughter died in vein. Her name was Abigail Burroughs, whose father sued the FDA for her daughter’s death. And this incident aroused the voice arguing that terminally ill patients should be given the right to demand experimental medical treatment.
Like the example of Burroughs indicates, there are problems in the current system of medical treatment. Today, many people are diagnosed as ‘terminally ill’ patients, who are defined as patients that their diseases cannot be cured with current methods of treatment. What can these patients do? They don’t have much choice, but waiting for death. On this issue, Cary Gross, MD, says, “terminally ill cancer patients are often willing to try unproven treatments when standard therapies are either unavailable or have failed to work. However, many are ineligible for clinical trials, and drug access through compassionate-use programs can be procedurally difficult to secure. Thus, access to experimental compounds is extremely limited for many patients.” Change is urgent and important.
Of course, there are some reasons why many people believe experimental medical treatment shouldn’t be given to patients. One of their biggest points is that experimental treatment, by its very definition of something being unproven to be safe, has a great possibility to be harmful to patients. They view experimental treatment as injecting an unidentified substance into any patient. However, such argument doesn’t stand. Clearly, introducing new drugs and medication isn’t simple even in the status quo. In the case of the U.S., the FDA strictly regulates researchers to undergo numerous times of animal experimentation before proceeding to further clinical trials. After thorough beforehand research, doctors will be providing treatments to patients. In other words, no mad scientist will be playing with the innocent patients.
Also, this policy benefits medical science and technology as a whole. Once patients are allowed to access experimental treatments, there would be more cases of testing new medications, which will foster medical research. The current system of clinical trial is tedious and slow compared to this. Also, testing would be more productive and accurate since researchers get to test on actual patients like Abigail Burroughs, thus able to prove whether the medicine really attains the desired effects or not. Advance in medical science also leads to more benefits to the society. More medicine available means more lives saved. Therefore, experimental medication is beneficial for sure.
The society doesn’t want any more unfortunate cases like Abigail Burroughs’s. Moreover, the government has responsibility to provide the best chance to live and the freedom of choice to its citizens. The new voice for experimental medication is upholding these values: saving lives and granting liberty. For the patients and for the society, terminally ill patients should be given the right to demand experimental treatment.